|Title:||Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin|
|Abstract:||The invention relates to a monohydrate polymorph PII.M of a compound of the formula ##STR1## exhibiting the following X-ray powder diffraction pattern The invention also relates to methods of preparing the above compound, pharmaceutical compositions containing the above compound, and methods of treating bacterial infections by administering the above compound.|
|Inventor(s):||Norris; Timothy (Gales Ferry, CT), McGarry; James J. (Ledyard, CT), Allen; Douglas J. M. (New London, CT)|
|Assignee:||Pfizer Inc. (New York, NY)|
Patent Claim Types:|
see list of patent claims
|Compound; Process; Use; Composition;|
Field: Not categorized
Back Citations: 2nd percentile
Forward Citations: 0th percentile
|Patent Number||Expiration Date|
|6,080,756||June 28, 2004|
|PCT Filed||July 05, 1996||PCT Application Number:||PCT/IB96/00653|
|PCT Publication Date:||March 06, 1997||PCT Publication Number:||WO97/08191|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.